Puma Biotechnology Inc. said its investigational breast-cancer treatment showed a 33% improvement in disease-free survival over a placebo in a phase III study.

Topics:  puma biotechnology inc   iii   breast-cancer   study   
BING NEWS:
  • Genetic Testing Could Inform Risk of Second Primary Breast Cancer
    Researchers found that young breast cancer survivors had a higher risk of second primary breast cancer if they had germline pathogenic variants that predispose patients to breast cancer.
    04/19/2024 - 3:45 am | View Link
  • Study explores how relationship with partner impacts breast cancer survivor's emotional and physical well-being
    Diagnosis and treatment of breast cancer place significant stress on survivors, their partners, and their relationships. A new study from researchers with Regenstrief Institute and Indiana ...
    04/18/2024 - 9:27 am | View Link
  • Don't Rule Out Breast Cancer Surgery for 90-Year-Olds
    And surgery was associated with a reduced risk of breast cancer-related death (P
    04/14/2024 - 5:00 pm | View Link
  • Some breast cancer patients could be at risk of another type of cancer, study reveals
    A new study found that women with breast cancer who have received chemotherapy are at an increased risk of developing lung cancer. Epic Research experts and other physicians commented.
    04/13/2024 - 6:25 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News